[1]
“In silico characterization of missense mutations in PI3K/AKT/mTOR signaling genes in breast cancer and their role in therapeutic resistance”, Ann Med Res , vol. 32, no. 12, pp. 541–551, Dec. 2025, Accessed: Jan. 08, 2026. [Online]. Available: http://annalsmedres.org/index.php/aomr/article/view/4890